Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders

E-ISSN： 1996-3181|14|6|745-756

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.14, Iss.6, 2015-08, pp. : 745-756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GLT-1 Upregulation as a Potential Therapeutic Target for Ischemic Brain Injury

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 5045-5055

Bentham Science Publishers

Access to resources Recommend Favorite

Glucose Transporter-1 as a New Therapeutic Target in Laryngeal Carcinoma

By Luo X-M Zhou S-H Fan J

The Journal of International Medical Research, Vol. 38, Iss. 6, 2010-11 ,pp. : 1885-1892

Field House Publishing

Access to resources Recommend Favorite

Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 112-120

Bentham Science Publishers

Access to resources Recommend Favorite

Modified Therapeutic Community Treatment for Offenders with MICA Disorders: Substance Use Outcomes

By Sullivan† Christopher McKendrick Karen Sacks Stanley Banks Steven

The American Journal of Drug and Alcohol Abuse, Vol. 33, Iss. 6, 2007-11 ,pp. : 823-832

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

By Bisaga A. Popik P. Bespalov A.Y. Danysz W.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2233-2248

Informa Healthcare

Access to resources Recommend Favorite